Learn More
Selleck Chemical LLC Ipilimumab (anti-CTLA-4) 1mg 477202-00-9 MDX-010, BMS-734016, Yervoy

Supplier: Selleck Chemical LLC A20011MG
Ipilimumab (anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor. MW : 148 kD. *For Research & Development use only. Product is not intended for drug, household, or human consumption.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.